Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
PureTech To Go Public Via London Offering
by Ann M. Thayer
June 1, 2015
| A version of this story appeared in
Volume 93, Issue 22
PureTech Health, a Boston-based tech-transfer and investment firm, intends to raise at least $160 million in an initial public offering of stock on the London Stock Exchange. The firm uses a network of more than 50 entrepreneurs and scientists across multiple disciplines to find and assess scientific and technological advances. It claims to evaluate more than 650 ideas per year and currently has 12 life sciences companies in its portfolio. A similar company, Boston-based Allied Minds, raised $212 million in mid-2014 through its London IPO.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X